Dalhousie University
Clinical Trials
53
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Supporting Couples' Perinatal Sexual Well-being: Testing the Introductory Modules of a Novel Prevention Program (STORK)
- Conditions
- Pregnancy
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Dalhousie University
- Target Recruit Count
- 22
- Registration Number
- NCT07036484
- Locations
- 🇨🇦
Dalhousie University, Halifax, Nova Scotia, Canada
An App to Reduce Social Media's Impact on Body Image and Eating Disorders
- Conditions
- Anorexia NervosaBulimiaBody DissatisfactionSelf-esteemPerfectionismDisordered Eating Behaviors
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Dalhousie University
- Target Recruit Count
- 50
- Registration Number
- NCT06910410
Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
- Conditions
- Pertussis (Whooping Cough)
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-08-19
- Lead Sponsor
- Dalhousie University
- Target Recruit Count
- 60
- Registration Number
- NCT06827470
Cognitive-Behavioural Couple Therapy for Sexual Interest/Arousal Disorder
- Conditions
- Sexual Interest/Arousal Disorder
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Dalhousie University
- Target Recruit Count
- 170
- Registration Number
- NCT06777277
- Locations
- 🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada
🇨🇦Dalhousie University, Halifax, Nova Scotia, Canada
🇨🇦Université de Montréal, Montréal, Quebec, Canada
An App Responding to Behaviour of People to Promote Mental Wellbeing in Anxious Youth
- Conditions
- AnxietySleep Problems
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Dalhousie University
- Target Recruit Count
- 101
- Registration Number
- NCT06748833
- Locations
- 🇨🇦
Dalhousie University, Halifax, Nova Scotia, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
News
Gene Therapy for Fabry Disease Shows Promise with $3.7 Million Cost Savings in Early-Stage Trial
A small-scale gene therapy study for Fabry disease enabled three of five male patients to discontinue costly enzyme-replacement therapy, generating $3.7 million in savings against $4 million research costs.
BioVaxys and Sona Nanotech Partner to Develop Novel Cancer Immunotherapy Combining DPX Platform with Gold Nanorod Technology
BioVaxys Technology and Sona Nanotech have formed a research collaboration to develop innovative cancer therapeutics by combining BioVaxys' DPX immune educating platform with Sona's targeted hyperthermia therapy using gold nanorods.
Ablation Shows Superior Outcomes as First-Line Treatment for Ventricular Tachycardia Post-Heart Attack
A new study suggests ablation should be considered as a first-line treatment for ventricular tachycardia (VT) in heart attack survivors, rather than a secondary option after medication failure.